1. Home
  2. WS vs NVAX Comparison

WS vs NVAX Comparison

Compare WS & NVAX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Worthington Steel Inc.

WS

Worthington Steel Inc.

SELL

Current Price

$39.72

Market Cap

1.9B

Sector

N/A

ML Signal

SELL

Logo Novavax Inc.

NVAX

Novavax Inc.

SELL

Current Price

$11.24

Market Cap

2.1B

Sector

Health Care

ML Signal

SELL

Company Overview

Basic Information
Metric
WS
NVAX
Founded
1955
1987
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Biological Products (No Diagnostic Substances)
Sector
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
1.9B
2.1B
IPO Year
2023
1996

Fundamental Metrics

Financial Performance
Metric
WS
NVAX
Price
$39.72
$11.24
Analyst Decision
Buy
Analyst Count
0
9
Target Price
N/A
★ $14.22
AVG Volume (30 Days)
437.3K
★ 8.1M
Earning Date
10-06-2026
11-05-2026
Dividend Yield
★ 1.63%
N/A
EPS Growth
N/A
★ 309.76
EPS
★ N/A
N/A
Revenue
★ $3,443,800,000.00
$1,123,479,000.00
Revenue This Year
$11.55
N/A
Revenue Next Year
$0.38
N/A
P/E Ratio
★ N/A
N/A
Revenue Growth
11.33
★ 64.69
52 Week Low
$27.22
$6.20
52 Week High
$49.17
$13.39

Technical Indicators

Market Signals
Indicator
WS
NVAX
Relative Strength Index (RSI) 61.42 50.30
Support Level $38.01 $7.93
Resistance Level $39.42 $11.73
Average True Range (ATR) 1.92 1.13
MACD 0.34 0.01
Stochastic Oscillator 80.29 28.62

Price Performance

Historical Comparison
WS
NVAX

About WS Worthington Steel Inc.

Worthington Steel Inc is a value-added metals processors with the ability to provide a diversified products and services that span a variety of end markets. It is a value-added processor of carbon flat-rolled steel and a producer of laser welded solutions and electrical steel laminations. It is one of the independent intermediate processors of carbon flat-rolled steel in the U.S. It occupy a niche in the steel industry by focusing on products requiring exact specifications. The company has one operating and reportable segment. It has presence in United States, Canada, Mexico, and Rest of world. The company has majority of sales from United States.

About NVAX Novavax Inc.

Novavax Inc is a biotechnology company that develops vaccines. The company works in the clinical stage of development with a focus on delivering novel products that prevent a broad range of diseases. It works together with its wholly owned Swedish subsidiary to produce vaccine candidates to respond to both known and emerging disease threats. The company believes its vaccine technology has the potential to be applied broadly to a wide variety of human infectious diseases. The company manages its business as one operating segment, an in-house early-stage R&D business to build a pipeline of high-value assets using its technology along with seeking to enter into partnerships to drive value creation for its assets.

Share on Social Networks: